ZIC2 drives colorectal cancer progression by regulating QPRT-mediated cell migration | Synapse
March 3, 2026Open Access
ZIC2 drives colorectal cancer progression by regulating QPRT-mediated cell migration
Key Points
ZIC2 promotes cancer progression, influencing cell migration and potentially affecting treatment outcomes.
A notable biomarker for colorectal cancer, ZIC2 regulates QPRT to enhance cell movement during tumor development.
Assessment using molecular pathway analysis reveals the critical role of ZIC2 in cancer biology.
Identifying ZIC2's role may enable improved prognostic strategies for colorectal cancer management.
Abstract
ZIC2 may serve as a valuable prognostic and prognostic biomarker in pan-cancer, including CRC. ZIC2 may promote the colorectal cancer progression by upregulating QPRT.